Finasteride e Dutasteride – avvertimenti di sicurezza aggiornati per effetti collaterali psichici e disfunzione sessuale.

HOW

Study type: not reported. N patients: not reported. Follow-up duration: not reported. Primary outcome: not reported.

WHAT WAS FOUND

The MHRA has reviewed the evidence for finasteride and dutasteride and identified a risk of suicidal thoughts and behaviours, leading to recommendations for risk minimisation measures. Exact numbers: not reported.

WHY IT MATTERS

The findings directly imply the need for updated safety warnings and risk minimisation strategies for patients using finasteride and dutasteride to address the identified risk of suicidal thoughts and behaviours.

LEVEL OF EVIDENCE

The document describes a review of evidence by a regulatory body (MHRA). Its interpretive weight pertains to regulatory safety assessments and recommendations.